ADIPEARL

Serial Number 98610045
656

Registration Progress

Application Filed
Jun 20, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
98610045
Deadline
July 15, 2025
Description
Respond to Examiner's Amendment or Priority Action
Filing Date
June 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
656
Status Date
Apr 15, 2025
Application
Pending
Classes
001 005 010

Rights Holder

Volumina Medical SA

99
Address
Route de la Corniche 5
Biopôle - Alanine
Epalinges 1066
CH

Ownership History

Volumina Medical SA

Original Applicant
99
Epalinges CH

Legal Representation

Attorney
Amy C. Ziegler

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description
Apr 15, 2025 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 15, 2025 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 15, 2025 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 15, 2025 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 14, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jan 14, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jan 14, 2025 DOCK D ASSIGNED TO EXAMINER
Jan 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 24, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 24, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Chemical polymers for use in the manufacture of pharmaceutical preparations and medical implants; biodegradable polymer compositions for use in the manufacture of pharmaceutical preparations and medical implants
Class 005
Pharmaceutical preparations, in particular for tissue enhancement and reconstruction, for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic medicine, for reconstructive medicine and for reconstructive surgery; medical and veterinary preparations and articles, in particular medical and veterinary preparations for treating the loss of soft tissue volume as well as for improving skin quality and volume contours in dermatology for tissue enhancement and reconstruction; pre-filled syringes filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical purposes; Pre-filled vials filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical and aesthetic medicine purposes; vials and syringes, pre-filled with a preparation for enabling cellular or tissular assembly for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic and medical purposes; injectable dermal fillers; biological implants, namely, implants comprising living tissue; implantable medicines for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans for tissue repair, enhancement, creation or regeneration; implantable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; none of the aforementioned in relation to medication and drugs for preventing, curing or slowing down the progression of cancer; polysaccharide compositions in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the dermal filler industry; polymeric biomaterials, in particular polymeric biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the cell therapy industry; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology, in particular for use in aesthetic medicine, aesthetic surgery, reconstructive surgery; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of microgels; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of particles, in the form of paste or putty, in the form of a dry material; implantable biomaterials in the form of three-dimensional volumes; injectable biocompatible material in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology used for tissues in particular soft tissues
Class 010
Surgical apparatus and instruments; prosthetic and filling materials, namely artificial materials for use in the replacement of soft tissue in humans, and artificial implants; artificial breast implants; medical implants made of artificial materials; biodegradable implants consisting of artificial materials; scaffolding material for the use of three-dimensional shapeable body implants, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; artificial materials for the repair and enhancement of human tissue, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; suture materials; syringes for injections; syringes, vials, containers and sterile bags as part of a kit for preparing a cellular or tissular construct, for preparing a pharmaceutical composition, and for mixing the composition with an anaesthetic agent; medical injection syringes; syringes for medical use; medical syringes for use in aesthetic surgery, in particular, in dermatology and reconstructive surgery; pharmaceutical implants made of artificial materials; implants made of artificial materials for guided tissue regeneration

Classification

International Classes
001 005 010